Fin Cascade

Prices as of 20 Nov 2026 close · Not investment advice

← Live events

Company newsHealthcare

Natco Pharma gets 7 checks from US drug regulator in Hyderabad

What happened✓ From the company's filing

The US Food and Drug Administration inspected Natco Pharma's plant in Kothur, Hyderabad from 12 to 20 November 2026. After the inspection it gave the company seven observations in Form 483. Natco Pharma said the observations are procedural in nature and it is confident of addressing them in time.

How big is this for Natco Pharma?SMALL

7observations

7 observations were listed after the 12 to 20 November inspection.

What changes for Natco PharmaOur view

  • −

    USFDA listed 7 observations at its Hyderabad plant

    Inspection was 12 to 20 November 2026

  • ?

    It is not yet known if any US approval will be delayed

  • +

    Natco Pharma said the observations are procedural and it is confident of addressing them in time

Who is affected

  • NATCOPHARMDirectly: The inspected Hyderabad plant is owned by Natco Pharma
Hindu Business Line ↗ · 21 Nov 2026, 3:02 PM ISTAI-written from public sources · Information, not advice · Not SEBI-registered